Podcast
Questions and Answers
Negative symptoms in schizophrenia primarily involve the enhancement of normal behaviors and functions.
Negative symptoms in schizophrenia primarily involve the enhancement of normal behaviors and functions.
False
Avolition in schizophrenia is characterized by an increase in interests, desires, and goals.
Avolition in schizophrenia is characterized by an increase in interests, desires, and goals.
False
Up to 20% of individuals with established schizophrenia experience persistent primary negative symptoms.
Up to 20% of individuals with established schizophrenia experience persistent primary negative symptoms.
True
Secondary negative symptoms can occur as a result of high-dose antipsychotic medication or chronic substance use.
Secondary negative symptoms can occur as a result of high-dose antipsychotic medication or chronic substance use.
Signup and view all the answers
The classification of negative symptoms in schizophrenia is always clear and well-defined.
The classification of negative symptoms in schizophrenia is always clear and well-defined.
Signup and view all the answers
Pharmacological studies have robustly proven an effective treatment for persistent primary negative symptoms.
Pharmacological studies have robustly proven an effective treatment for persistent primary negative symptoms.
Signup and view all the answers
Expressive deficits in schizophrenia include a blunted affect and diminished facial emotional expression.
Expressive deficits in schizophrenia include a blunted affect and diminished facial emotional expression.
Signup and view all the answers
Earlier effective treatment of psychotic illness may decrease the development of negative symptoms over time.
Earlier effective treatment of psychotic illness may decrease the development of negative symptoms over time.
Signup and view all the answers
Antipsychotic medications have been conclusively proven to reduce negative symptoms in all schizophrenia spectrum disorders.
Antipsychotic medications have been conclusively proven to reduce negative symptoms in all schizophrenia spectrum disorders.
Signup and view all the answers
Ginkgo biloba is a COX-2 inhibitor that shows some benefit for negative symptoms in schizophrenia spectrum disorders.
Ginkgo biloba is a COX-2 inhibitor that shows some benefit for negative symptoms in schizophrenia spectrum disorders.
Signup and view all the answers
Repetitive Transcranial Magnetic Stimulation (rTMS) has definitive positive outcomes for treating negative symptoms.
Repetitive Transcranial Magnetic Stimulation (rTMS) has definitive positive outcomes for treating negative symptoms.
Signup and view all the answers
Patients who misuse psychoactive substances tend to experience more negative symptoms than those who do not.
Patients who misuse psychoactive substances tend to experience more negative symptoms than those who do not.
Signup and view all the answers
There is inadequate evidence supporting the effectiveness of specific pharmacological treatments for negative symptoms.
There is inadequate evidence supporting the effectiveness of specific pharmacological treatments for negative symptoms.
Signup and view all the answers
Environmental factors like institutionalization can influence the persistence of negative symptoms.
Environmental factors like institutionalization can influence the persistence of negative symptoms.
Signup and view all the answers
Clinical trials have shown that primary negative symptoms always improve with antipsychotic medication.
Clinical trials have shown that primary negative symptoms always improve with antipsychotic medication.
Signup and view all the answers
Donepezil has consistently demonstrated positive effects in treating negative symptoms in schizophrenia patients.
Donepezil has consistently demonstrated positive effects in treating negative symptoms in schizophrenia patients.
Signup and view all the answers
Amisulpride has been shown to have superior efficacy against negative symptoms compared to all other SGAs.
Amisulpride has been shown to have superior efficacy against negative symptoms compared to all other SGAs.
Signup and view all the answers
Clozapine is established as the most effective treatment for negative symptoms in treatment-resistant schizophrenia.
Clozapine is established as the most effective treatment for negative symptoms in treatment-resistant schizophrenia.
Signup and view all the answers
A meta-analysis of 38 RCTs demonstrated no statistically significant reduction in negative symptoms when using SGAs.
A meta-analysis of 38 RCTs demonstrated no statistically significant reduction in negative symptoms when using SGAs.
Signup and view all the answers
The use of mGlu2/3 receptor agonists has been successful in improving negative symptoms over placebo.
The use of mGlu2/3 receptor agonists has been successful in improving negative symptoms over placebo.
Signup and view all the answers
Antidepressant augmentation has been found to reduce affective flattening and avolition among negative symptoms.
Antidepressant augmentation has been found to reduce affective flattening and avolition among negative symptoms.
Signup and view all the answers
Topiramate has strong evidence supporting its use as an adjunct for the improvement of negative symptoms.
Topiramate has strong evidence supporting its use as an adjunct for the improvement of negative symptoms.
Signup and view all the answers
Quetiapine has been shown to be more effective than risperidone in treating negative symptoms.
Quetiapine has been shown to be more effective than risperidone in treating negative symptoms.
Signup and view all the answers
Evidence for the efficacy of NMDA receptor-affecting drugs like glycine is overwhelmingly consistent.
Evidence for the efficacy of NMDA receptor-affecting drugs like glycine is overwhelmingly consistent.
Signup and view all the answers
Study Notes
Treatment of Negative Symptoms
- Antipsychotic medications and various augmentations might be beneficial for reducing negative symptoms in schizophrenia spectrum disorders
- Limited evidence for specific pharmacological treatments for negative symptoms
- A trial of add-on medication with potential efficacy (e.g., antidepressants) may be considered
- Early analysis found no consistent evidence for the superiority of any individual SGA.
- A meta-analysis of 38 RCTs found a statistically significant reduction in negative symptoms with SGAs, but did not reach the threshold for "minimally detectable clinical improvement over time".
- There is robust data suggesting superior efficacy against negative symptoms with Amisulpride, Cariprazine, Olanzapine, Quetiapine, and augmentation with Aripiprazole
- Clozapine is the only medication with convincing superiority for treatment-resistant schizophrenia (TRS), but its efficacy for negative symptoms is uncertain, particularly in the short-term
- Non-antipsychotic interventions targeting glutamate pathways showed disappointing results
- Recommendations for additional antibiotics and anti-inflammatory drugs suggest possible improvements
- A Cochrane review concluded that antidepressant augmentation might reduce symptoms like affective flattening, alogia, and avolition
- Evidence suggested some efficacy for SSRIs (e.g., fluvoxamine, citalopram) and α2 receptor antagonists (e.g., mirtazapine, mianserin)
- Limited evidence supports topiramate as an adjunct for negative symptom improvement
Negative Symptoms
- Negative symptoms represent the absence or diminishment of normal behaviors and functions
- Contribute to long-term morbidity and poor functional outcome in patients with schizophrenia
- In individuals with established schizophrenia, negative symptoms are seen in up to three-quarters, with up to 20% having persistent primary negative symptoms
- Persistent negative symptoms contribute to:
- Long-term morbidity
- Poor functional outcome in patients with schizophrenia
Subdomains of Negative Symptoms
- Expressive Deficits:
- Decrease in verbal output or verbal expressiveness
- Flattened or blunted affect
- Diminished facial emotional expression
- Poor eye contact
- Decreased spontaneous movement and lack of spontaneity
- Avolition/Amotivation:
- Subjective reduction in interests, desires, and goals
- Behavioral reduction in purposeful acts
- Includes lack of self-initiated social interactions
Classification of Negative Symptoms
- Primary Negative Symptoms:
- Enduring deficit state
- Predict poor prognosis, stable over time
- Secondary Negative Symptoms:
- Consequent upon positive psychotic symptoms, depression, or demoralization
- Can be linked to medication side effects (e.g., bradykinesia)
- May stem from chronic substance/alcohol use, high-dose antipsychotic medication, social deprivation, lack of stimulation, and hospitalization
General Observations
- The presence of negative symptoms in First-Episode Psychosis relates to poor outcomes regarding recovery and social functioning
- Earlier effective treatment of psychotic illness is likely to reduce the development of negative symptoms over time
- Early clinical pictures characterized by negative symptoms may delay presentation to clinical services and are associated with longer durations of untreated psychosis
- While improving negative symptoms, the effect of antipsychotic medication may be limited to secondary negative symptoms in acute episodes
- No consistent evidence favors SGAs over FGAs in treating negative symptoms
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz explores the pharmacological strategies for treating negative symptoms in schizophrenia spectrum disorders. It covers the efficacy of various antipsychotics, the role of add-on medications, and the findings from recent meta-analyses. Test your knowledge on the latest evidence-based approaches in this area.
